ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGT Argent Biopharma Limited

6.00
-0.50 (-7.69%)
30 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -7.69% 6.00 5.00 7.00 6.50 6.00 6.50 24,715 16:02:50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Result of Equity Issue

15/07/2003 6:06pm

UK Regulatory


RNS Number:5938N
ReGen Therapeutics PLC
15 July 2003


15 July 2003


ReGen Therapeutics Plc



ReGen Therapeutics placing raises #954,000


ReGen Therapeutics Plc ('ReGen' or the 'Company') announces that it has today
placed with new and existing shareholders 63.6 million new ordinary shares ('New
Shares') at 1.50p per share to raise #954,000 before expenses ('Placing').


Application has been made for the New Shares to be admitted to the Alternative
Investment Market of the London Stock Exchange plc and dealings are expected to
commence at 8.00 am on 22 July 2003.


Executive Chairman Percy Lomax commented "The placing price is double the April
placing price of 0.75p. Since the beginning of April 2003, the Company has
raised approximately #1.67m through placing of new shares and disposal of
investments in New Opportunities Investment Trust plc and Jubilee Investment
Trust plc.


I am very pleased to see the Company in a financial position which enables it to
continue the current scientific programme, and also that there was such a demand
in the Placing for shares that investors had to be scaled back. I will also be
adding to my own holding by subscribing for 333,333 new shares in the Placing".


For further information please contact:


Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
ROIRAMRTMMMBBIJ

1 Year Argent Biopharma Chart

1 Year Argent Biopharma Chart

1 Month Argent Biopharma Chart

1 Month Argent Biopharma Chart

Your Recent History

Delayed Upgrade Clock